| Literature DB >> 11254642 |
T Madan1, U Kishore, M Singh, P Strong, E M Hussain, K B Reid, P U Sarma.
Abstract
The protective effects of intranasal administration of amphotericin B (AmB), human SP-A, SP-D and a 60-kDa fragment of SP-D (rSP-D) were examined in a murine model of invasive pulmonary aspergillosis (IPA). The untreated group of IPA mice showed no survival at 7 days postinfection. Treatment with AmB, SP-D, and rSP-D increased the survival rate to 80, 60, and 80%, respectively, suggesting that SP-D (and rSP-D) can protect immunosuppressed mice from an otherwise fatal challenge with Aspergillus fumigatus conidia.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11254642 PMCID: PMC98214 DOI: 10.1128/IAI.69.4.2728-2731.2001
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441